The 2023 ESC Guidelines provide updated recommendations for the management of endocarditis.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“A really important message from the document is that once patients have reached a state of clinical stability, and we define what that stability is in the document, they can be switched to oral antibiotics rather than spending the entire 6 weeks in the hospital, which can be detrimental sometimes for patients.”
“Patient education is therefore paramount to early diagnosis and treatment. Those with valvular heart disease or previous heart valve surgery should be particularly diligent with regards to prevention and recognizing symptoms.”
“The mortality rate is extremely high and therefore preventive strategies in patients at high risk are pivotal.”
Supports multidisciplinary endocarditis care pathways; extends prior ESC guidance with integrated imaging criteria.
3 Representing the European Association for Cardio-Thoracic Surgery (EACTS) ESC Clinical Practice Guidelines (CPG) Committee: listed in the Appendix.ESC subspecialty communities having participated in the development of this document: Associations: Association of Cardiovascular Nursing & Allied Professions (ACNAP), Association for Acute CardioVascular Care (ACVC), European Association of Cardiovascular Imaging (EACVI), European Association of Preventive Cardiology (EAPC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA), and Heart Failure Association (HFA).Councils: Council for Cardiology Practice, Council on Stroke.
No takes yet. Share an insight, caveat, or question.
Delgado et al. (2023) conducted a review in endocarditis. The 2023 ESC Guidelines provide updated recommendations for the management of endocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: